
Castle Biosciences CSTL
$ 23.99
-2.87%
Quarterly report 2025-Q3
added 11-03-2025
Castle Biosciences P/CF Ratio 2011-2026 | CSTL
Annual P/CF Ratio Castle Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.9 | -117 | -15.9 | -56.8 | 247 | 42.4 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 247 | -117 | 18.6 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
28.3 | $ 110.3 | -2.8 % | $ 33.5 B | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 30.28 | -4.87 % | $ 1.54 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Neuronetics
STIM
|
-3.98 | $ 1.4 | 4.89 % | $ 92.3 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
16.6 | $ 13.25 | -2.18 % | $ 3.76 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.61 | -0.7 % | $ 61.9 M | ||
|
BioNano Genomics
BNGO
|
-0.486 | $ 1.15 | - | $ 6.26 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 44.54 | -4.74 % | $ 2.66 B | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 159.38 | -3.48 % | $ 7.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 196.09 | -1.04 % | $ 21.8 B | ||
|
Organovo Holdings
ONVO
|
-0.328 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
-1.87 | - | -16.95 % | $ 1.54 M | ||
|
DarioHealth Corp.
DRIO
|
-1.27 | $ 8.45 | - | $ 33.7 M | ||
|
Waters Corporation
WAT
|
30.1 | $ 289.91 | -3.54 % | $ 17.3 B | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
19.6 | $ 117.59 | -5.48 % | $ 18.7 B | ||
|
PerkinElmer
PKI
|
22.5 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
0.888 | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 8.85 | -3.33 % | $ 1.92 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Personalis
PSNL
|
-5.62 | $ 6.33 | -13.59 % | $ 375 M | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 264.96 | -1.27 % | $ 22 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.45 | -1.68 % | $ 269 M | ||
|
Psychemedics Corporation
PMD
|
-11.4 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
-2.44 | $ 25.68 | -3.24 % | $ 33.3 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 16.68 | -4.52 % | $ 889 M | ||
|
Quotient Limited
QTNT
|
-2.36 | - | -11.32 % | $ 1.1 M | ||
|
Syneos Health
SYNH
|
20.8 | - | - | $ 4.46 B | ||
|
Renalytix AI plc
RNLX
|
-0.754 | - | 5.66 % | $ 22.7 M | ||
|
VolitionRx Limited
VNRX
|
-2.12 | $ 0.2 | 1.97 % | $ 19.2 M | ||
|
Biodesix
BDSX
|
-1.89 | $ 14.27 | -2.26 % | $ 1.85 B |